HUM vs PHAT · P/E 39, rev $117.76B vs rev $55.3M
Humana Inc (HUM) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the HUM and PHAT stock pages for the full models.
Not investment advice.